(Q45330295)

13 December 2017

title

Understanding variation in primary prostate cancer treatment within the Veterans Health Administration (English)

1 reference

13 December 2017

0 references

7

Nancy L Keating

1 reference

13 December 2017

4

Barbara J McNeil

1 reference

13 December 2017

2

Mary Beth Landrum

1 reference

13 December 2017

5

Samuel R Bozeman

1 reference

13 December 2017

Vinod E Nambudiri

1

1 reference

13 December 2017

Elizabeth B Lamont

series ordinal

3

1 reference

13 December 2017

Stephen J Freedland

series ordinal

6

1 reference

13 December 2017

language of work or name

English

0 references

publication date

13 January 2012

1 reference

13 December 2017

1 reference

13 December 2017

volume

79

1 reference

13 December 2017

issue

3

1 reference

13 December 2017

page(s)

537-545

1 reference

Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Quality of life and satisfaction with outcome among prostate-cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Contemporary trends in low risk prostate cancer: risk assessment and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Factors Associated With Initial Therapy for Clinically Localized Prostate Cancer: Prostate Cancer Outcomes Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Managed care market share and primary treatment for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Development of a comorbidity index using physician claims data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Adjustments for center in multicenter studies: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Use of health services by previously uninsured Medicare beneficiaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Geographic variation across veterans affairs medical centers in the treatment of early stage prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Relationship of distance from a radiotherapy facility and initial breast cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Racial differences in medical mistrust among men diagnosed with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

The role of primary androgen deprivation therapy in localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.013

10.1016/J.UROLOGY.2011.11.013

7 January 2021

Identifiers

DOI

1 reference

13 December 2017

1 reference